These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29977480)
1. An Artificial Neural Network Integrated Pipeline for Biomarker Discovery Using Alzheimer's Disease as a Case Study. Zafeiris D; Rutella S; Ball GR Comput Struct Biotechnol J; 2018; 16():77-87. PubMed ID: 29977480 [TBL] [Abstract][Full Text] [Related]
2. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. Thal DR; Attems J; Ewers M J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313 [TBL] [Abstract][Full Text] [Related]
3. A deep learning model for detection of Alzheimer's disease based on retinal photographs: a retrospective, multicentre case-control study. Cheung CY; Ran AR; Wang S; Chan VTT; Sham K; Hilal S; Venketasubramanian N; Cheng CY; Sabanayagam C; Tham YC; Schmetterer L; McKay GJ; Williams MA; Wong A; Au LWC; Lu Z; Yam JC; Tham CC; Chen JJ; Dumitrascu OM; Heng PA; Kwok TCY; Mok VCT; Milea D; Chen CL; Wong TY Lancet Digit Health; 2022 Nov; 4(11):e806-e815. PubMed ID: 36192349 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Classification and Biomarker Identification of Alzheimer's Disease with Random Forest Algorithm. Song M; Jung H; Lee S; Kim D; Ahn M Brain Sci; 2021 Apr; 11(4):. PubMed ID: 33918453 [TBL] [Abstract][Full Text] [Related]
5. Application of artificial neural network model in diagnosis of Alzheimer's disease. Wang N; Chen J; Xiao H; Wu L; Jiang H; Zhou Y BMC Neurol; 2019 Jul; 19(1):154. PubMed ID: 31286894 [TBL] [Abstract][Full Text] [Related]
6. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. Cavedo E; Lista S; Khachaturian Z; Aisen P; Amouyel P; Herholz K; Jack CR; Sperling R; Cummings J; Blennow K; O'Bryant S; Frisoni GB; Khachaturian A; Kivipelto M; Klunk W; Broich K; Andrieu S; de Schotten MT; Mangin JF; Lammertsma AA; Johnson K; Teipel S; Drzezga A; Bokde A; Colliot O; Bakardjian H; Zetterberg H; Dubois B; Vellas B; Schneider LS; Hampel H J Prev Alzheimers Dis; 2014 Dec; 1(3):181-202. PubMed ID: 26478889 [TBL] [Abstract][Full Text] [Related]
7. Early detection of Alzheimer's disease using neuropsychological tests: a predict-diagnose approach using neural networks. Mukherji D; Mukherji M; Mukherji N; Brain Inform; 2022 Sep; 9(1):23. PubMed ID: 36166157 [TBL] [Abstract][Full Text] [Related]
8. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
10. A 5-min Cognitive Task With Deep Learning Accurately Detects Early Alzheimer's Disease. Almubark I; Chang LC; Shattuck KF; Nguyen T; Turner RS; Jiang X Front Aging Neurosci; 2020; 12():603179. PubMed ID: 33343337 [No Abstract] [Full Text] [Related]
11. Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer's disease. Wang Q; Chen K; Su Y; Reiman EM; Dudley JT; Readhead B Brain Commun; 2022 Feb; 4(1):fcab293. PubMed ID: 34993477 [TBL] [Abstract][Full Text] [Related]
12. Ensemble Model for Diagnostic Classification of Alzheimer's Disease Based on Brain Anatomical Magnetic Resonance Imaging. Khan YF; Kaushik B; Chowdhary CL; Srivastava G Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553199 [TBL] [Abstract][Full Text] [Related]
13. Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review. Carpenter KA; Huang X Curr Pharm Des; 2018; 24(28):3347-3358. PubMed ID: 29879881 [TBL] [Abstract][Full Text] [Related]
15. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043 [TBL] [Abstract][Full Text] [Related]